<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Projects on Van der Laan &amp; Science</title>
    <link>https://swvanderlaan.github.io/project/</link>
    <description>Recent content in Projects on Van der Laan &amp; Science</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <copyright>&amp;copy; 1979-2018 Sander W. van der Laan</copyright>
    <lastBuildDate>Tue, 10 Jul 2018 00:00:00 +0000</lastBuildDate>
    
	<atom:link href="https://swvanderlaan.github.io/project/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>Mendelian randomisation</title>
      <link>https://swvanderlaan.github.io/project/mendelian-randomisation/</link>
      <pubDate>Tue, 10 Jul 2018 00:00:00 +0000</pubDate>
      
      <guid>https://swvanderlaan.github.io/project/mendelian-randomisation/</guid>
      <description>Mendel&amp;rsquo;s Second Law, the law of independent assortment, underlies the principle of Mendelian randomisation (MR) which make use of the inherent properties of the human genome to enable causal inference for a biomarker. The invariant nature of the genome, and the random distribution of alleles from parents to offspring at the time of conception (Mendel&amp;rsquo;s Second Law), imply that the genetic information, is not influenced by disease status or the presence of risk factors (reverse causality); therefore it should be free from confounding.</description>
    </item>
    
    <item>
      <title>Cardiovascular genetics</title>
      <link>https://swvanderlaan.github.io/project/genetics/</link>
      <pubDate>Tue, 03 Oct 2017 00:00:00 +0000</pubDate>
      
      <guid>https://swvanderlaan.github.io/project/genetics/</guid>
      <description>[More information to follow]</description>
    </item>
    
    <item>
      <title>Functional genomics</title>
      <link>https://swvanderlaan.github.io/project/functional-genomics/</link>
      <pubDate>Tue, 03 Oct 2017 00:00:00 +0000</pubDate>
      
      <guid>https://swvanderlaan.github.io/project/functional-genomics/</guid>
      <description>[More information to follow]</description>
    </item>
    
    <item>
      <title>Other work</title>
      <link>https://swvanderlaan.github.io/project/other/</link>
      <pubDate>Tue, 03 Oct 2017 00:00:00 +0000</pubDate>
      
      <guid>https://swvanderlaan.github.io/project/other/</guid>
      <description>[More information to follow]</description>
    </item>
    
    <item>
      <title>High-throughput imaging</title>
      <link>https://swvanderlaan.github.io/project/high-throughput-imaging/</link>
      <pubDate>Wed, 27 Apr 2016 00:00:00 +0000</pubDate>
      
      <guid>https://swvanderlaan.github.io/project/high-throughput-imaging/</guid>
      <description>Since the start of the Athero-Express Biobank Study in 2002 we have collected atherosclerotic plaque samples of over 3,500 patients. Each of these samples have been stained for various plaque characteristics, including smooth muscle cells based on smooth-muscle cell actin (SMA), macrophages based on CD68, intraplaque hemorrhage, and intraplaque microvessels based on CD34 among others. The community standard is to analyze histological slides manually, with the downside of inter- and intra-observer variability leading to a &amp;ldquo;noisy&amp;rdquo; phenotype.</description>
    </item>
    
  </channel>
</rss>